Trial Search Results

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Target PharmaSolutions, Inc.

Stanford Investigator(s):


Inclusion Criteria:

   - Adult patients (age 18 or older) being treated or managed for PBC

Exclusion Criteria:

   - Inability to provide written informed consent

   - Simultaneous enrollment in another prospective registry or clinical trial or study
   where PBC treatment outcomes are reported, except where approved or conducted as an
   adjunct project of TARGET-PBC

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jennifer Smart